Bristol-Myers Squibb to Take Part in Guggenheim Healthcare Talks Idea Forum

NEW YORK–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24BMY&src=ctag” target=”_blank”gt;$BMYlt;/agt;–Bristol-Myers
Squibb Company
(NYSE: BMY) will take part in a fireside chat at the
Guggenheim Healthcare Talks Idea Forum on Thursday, February 14, 2019,
in New York. Giovanni
Caforio, M.D.
, chairman and chief executive officer will answer
questions at 11:00 a.m. ET.

Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
Materials related to the presentation will be available at the same
website at the start of the live webcast. An archived edition of the
session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedInTwitter,
YouTube
and Facebook.

Contacts

Media:
Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com

Investors:
Tim
Power, 609-252-7509, timothy.power@bms.com
Bill
Szablewski, 609-252-5894, william.szablewski@bms.com

error: Content is protected !!